WHOCC
Postal address:
Norwegian Institute of Public Health
WHO Collaborating Centre for Drug Statistics Methodology
Postboks 222 Skøyen
0213 Oslo
Norway

Visiting/delivery address:
Myrens verksted 6H
0473 Oslo
Norway

Tel:  +47 21 07 81 60
E-mail:
 
Copyright/Disclaimer

New search    Hide text from Guidelines

A ALIMENTARY TRACT AND METABOLISM
A08 ANTIOBESITY PREPARATIONS, EXCL. DIET PRODUCTS
A08A ANTIOBESITY PREPARATIONS, EXCL. DIET PRODUCTS

Low-energy diets, see V06AA.


A08AA Centrally acting antiobesity products

Amfetamine, which is commonly used in psychiatry, is classified in N06B - Psychostimulants, agents used for ADHD and nootropics.


Fenfluramine indicated for the treatment of seizures associated with Dravet syndrome is classified in N03AX - Other antiepileptics.

A08AB Peripherally acting antiobesity products
A08AX Other antiobesity drugs

Liraglutide and semaglutide used as antiobesity drugs are classified as blood glucose lowering drugs in A10BJ.

Last updated: 2024-01-26